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INTRODUCTION
Glutathione peroxidase (GPx) is a mammalian selenoen-
zyme which functions as a catalytic antioxidant and pro-
tects various organisms from oxidative stress and
cellular membrane damage.1 GPx catalyses the reduction
of harmful peroxides using glutathione (GSH) as the
reducing substrate2 according to the following equation:
ROOH + 2GSH → ROH + GSSG + H2O Eq. 1
On the other hand, it is well known that the nucleophilic
reactivity and radical scavenging properties of selenium
contribute to the biological activity of selenium com-
pounds. Consequently, the use of low molecular weight
compounds (GPx mimics) able to circumvent the difficulty
linked to the use of the enzyme itself is strongly encour-
aged. With this in mind, some simple seleno-organic com-
pounds have been widely studied3 and shown to have GPx
mimicking activity in vitro.4 Among them the most
promising drug was Ebselen (PZ 51, 2-phenyl-1,2-benzo-
isoselenazol-3-(2H)-one), a heterocyclic compound that
functions as an antioxidant.5 Recently, much attention has
been devoted to the design of new synthetic analogues of
Ebselen able to mimic the GPx activity. One of the first
studies addressing this problem in a series of diselenides
was the study of Wilson et al.6 The Iwaoka and Tomoda
groups and others continued working on this issue, thus
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demonstrating the important role of basic amino groups
in the intramolecular interaction between nitrogen atom
and selenium.7 In the same way, Mugesh and co-workers
developed novel analogues to increase the GPx mimick-
ing activity. Various derivatives having in their structure
either the diferrocenyl diselenide or ditelluride moieties
were thus designed and synthesized.8,9 In this series, dis-
elenide derivatives bearing a primary amino group were
not studied in the GPx mimic model.
On the other hand, beside its thiol peroxidase-like activity,
Ebselen has been found to have radical scavenging proper-
ties.10 In animal model studies, Ebselen was shown to reduce
oxidative stress in ischemia-reperfusion in heart11 and to have
neuroprotective effects in brain.12,13 Nevertheless, some studies
suggested that the unique mechanism of the antioxidant activ-
ity of Ebselen seemed specific to its capability to reduce the
harmful peroxides rather than to its radical scavenging proper-
ties.14 In the light of these findings and taking into account the
increasing role played by this kind of compounds, we were
interested in investigating not only the GPx mimic effect but
also the antioxidant properties of new synthetic analogues of
Ebselen. Here we report data obtained for four selenide and
diselenide derivatives compared to Ebselen in in vitro experi-
mental models: (i) glutathione peroxidase activity using kinetic
assays and peroxidase-catalysed oxidation monitored by EPR
spin trapping technique; and (ii) the antioxidant profile by
using a free radical generating system (ABTS/H2O2/MetMb)
and lipid peroxidation of an emulsion of linoleic acid followed
by UV–visible spectrophotometry analysis.
MATERIALS AND METHODS
Chemicals
All synthetic compounds – (2-phenyl-1,2-benzoisoselen-
azol-3(2H)-one (Ebselen); ethyl-benzo-1,2-selenazine-4-
one-3-carboxylate [1]; 2-methylselenobenzoylcyanide [2];
2,2′-diamino-diphenyldiselenide [3]; and 2,2′-diselenopy-
ridin [4] – were provided by the Laboratory of Organic
Chemistry (University of Liège, Belgium) (Scheme 1).
Benzenethiol (PhSH) was purchased from Janssen-
Chemica (Belgium). Methanol was from UCB-Pharma
(Belgium). 2-Thiobarbituric acid (TBA), trichloroacetic
acid (TCA), phosphate salts (NaH2PO4.2H2O and
Na2HPO4) and hydrogen peroxide were obtained from
Merck (Belgium). CHAPS (3-[(3-cholamidopropyl)-
dimethylammonio]-1-propane sulfonate) and diethylenete-
tramine pentaacetic acid (DTPA) were obtained from
Sigma (Belgium). Horseradish peroxidase (HRP) was pur-
chased from Boehringer Mannheim. The precise concentra-
tion of hydrogen peroxide (Merck, 30% H2O2) was
determined by titration with potassium permanganate. 5,5-
Dimethyl-1-pyrroline-N-oxide (DMPO) was obtained from
Sigma-Aldrich (Belgium) with further purification with
charcoal as previously described by Green and Hill.15 For
EPR and lipid peroxidation experiments, compounds were
dissolved daily in DMSO or methanol (analytical grade,
Merck). 2,2-Azinobis (3-ethylbenzothiazoline-6-sulfonate;
ABTS) was purchased from Aldrich (Belgium). All other
reagents were of analytical grade.
Kinetic analysis
The GPx-like catalytic activity of the tested compounds
was initiated by the reaction of 37.5 mM H2O2 with a
methanolic solution of 10 mM PhSH used as glutathione
alternative.7 The reaction was monitored at 25°C by UV
spectroscopy at 305 nm by following the absorbance
increase due to the formation of diphenyldisulfide
(PhSSPh). The molar extinction coefficient of PhSSPh
(ε = 1.24 × 103 M–1cm–1) at this wavelength was at least
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Scheme 1. Chemical structure of Ebselen and the related analogues, selenides [1,2] and diselenides [3,4] used in this study.
> 5 times larger than that of PhSH (ε = 9.0 M–1cm–1
under the same conditions). Kinetics of the reaction were
compared with that of the reference compound Ebselen
(Perkin-Elmer Lambda 15 UV:VIS spectrophotometer).
Lipid peroxidation experiments
Stock solutions of the drugs (10–2 M), prepared in
DMSO, were diluted to the final concentration of 100
µM in 50 mM phosphate buffer pH 7.4 (total volume 2
ml). To a mixture containing 200 mg of CHAPS, 0.2 ml
of linoleic acid (final concentration 6.4 mM) and 100 ml
of the chelexed phosphate buffer were added 20 µl of
10–2 M drug. The mixture reaction was irradiated (from
cesium-137 source at the total dose rate of 10,000 rads)
to produce •OH able to trigger lipid peroxidation. Then,
0.5 ml of the irradiated solution was added to 0.5 ml of
TCA and 2 ml of TBA (26 mM) in 50 mM Tris-HCl
buffer at pH 7.0 in order to detect the final amount of
lipid peroxidation products.16 After extraction with 2 ml
of n-butanol, the absorbance of the lipid peroxidation
product–TBA complex of each sample was measured by
monitoring the absorbance at 540 nm, with n-butanol as
internal reference (Perkin-Elmer Lambda 15 UV:VIS
spectrophotometer). Each assay was done in triplicate
and repeated at least three times.
Evaluation of the antioxidant activity of Ebselen analogues
on the formation of the radical cation (ABTS•+)
The experiment was performed in 50 mM phosphate buffer
(pH 7.4) with the peroxidase system metmyoglobin
(MetMb)/H2O2 in the presence of the ABTS substrate (λmax,
342 nm) with or without addition of the Ebselen analogue.
The ferrylmyoglobin radical formed from MetMb and H2O2
produced the ABTS radical cation (ABTS•+) with maximal
absorbance at 734 nm. The antioxidant capacity of the drug
under investigation was followed by the absorbance value at
734 nm. The tested compounds were used at final concen-
trations ranging from 10–5–10–4 M and added just after the
reaction has been started by H2O2 addition. All measure-
ments were carried out at room temperature on an UV-visi-
ble spectrophotometer (Perkin-Elmer, Lambda 15).
EPR spin trapping investigation on the peroxidase-
catalysed thiyl radical generation
The experiments were performed in 50 mM phosphate
buffer (pH 7.4) in the presence of 100 mM DMPO in a
total volume of 1 ml. The reaction started after the addi-
tion of the drug (10–4 M, in 1% DMSO) to the following
system: HRP (25 µg/ml), GSH (10 mmol/l), H2O2 (1
mM), and DTPA (0.5 mmol/l). The reaction mixture was
immediately transferred into a quartz flat cell in the EPR
cavity (Bruker spectrometer ESP 300 E; Bruker, Karls-
ruhe, Germany). The EPR signal, corresponding to the
spin adduct of DMPO/thiyl (GS•) resulted from the reac-
tion of DMPO with the GS• radicals produced by the
HRP enzymatic activity on GSH. The EPR signal
obtained in the absence of the drug was taken as the con-
trol spectrum.
EPR spectra were monitored at room temperature with
the following instrument settings: microwave power, 20
mW; modulation frequency, 100 kHz; modulation
amplitude, 1.0 G; centre of field, 3480 G; and sweep
width, 100 G. The other parameters are listed in the cap-
tions to the figures.
RESULTS
Estimation of GPx-like activity
The results of the initial reduction rate of H2O2, obtained
by monitoring the increase of the UV absorption at 305
nm due to the diphenyl disulfide (PhSSPh) formed, are
listed in Table 1. In the absence of catalysts with poten-
tial GPx-like activity, an exceedingly slow oxidation of
PhSH took place (k = 0.91 mM s–1). Among the studied
compounds, diselenide derivatives [3] and [4] strongly
accelerated the reduction rate of H2O2 with k values of
6.79 and 12.23 mM s–1, respectively. In contrast, the
selenide derivatives [1,2] were weakly active, with an
efficiency of 1.37 and 0.95 mM s–1 almost similar to that
of the reference drug (Ebselen, k = 1.16 mM s–1) which,
in this model, was poorly active (Table 1).
Effect of Ebselen and analogues on the lipid
peroxidation of linoleic acid
Radiation-induced lipid peroxidation was designed to fol-
low the capability of Ebselen analogues to inhibit the for-
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Table 1. Kinetics of the reduction of the hydrogen peroxide
molecule catalysed by Ebselen analogues (10–4 M) in the
presence of benzenethiol (PhSH) taken as glutathione alternative.









mation of peroxidized lipid derived from the reaction of
hydroxyl radical with linoleic acid. The results indicated
that the diselenide derivatives [3] and [4], at 10–4 M, signifi-
cantly inhibited lipid peroxidation (P< 0.001 versus Ebselen;
Fig. 1). Likewise, when Ebselen or selenide derivatives [1]
and [2] were added to the reaction mixture, a decrease of
the lipid peroxidation was also observed but to a lesser
degree (P < 0.05 and P < 0.01 versus Ebselen, for com-
pounds [1] and [2]), although still significant compared to
control (Fig. 1). In the model of lipid peroxidation, the
order of efficacy of the tested drugs was as follows: [4] >
[3] > Ebselen > [1] > [2].
Evaluation of the antioxidant activity using the ABTS
assay
The use of H2O2 and MetHb allowed the formation of fer-
rylmyoglobin (MbFe (IV)=O), with a subsequent electron
transfer from the ABTS substrate, resulting in the forma-
tion of the ABTS radical cation, the production of which was
followed spectrophotometrically (ABTS/MetMb/H2O2 sys-
tem). This assay allowed the determination of the anti-rad-
ical activity of the selected compounds under hydrophilic
conditions. In the absence of the Ebselen analogues, the
absorbance due to the formation of the ABTS•+ radical
cation was taken as the 100% reference value (Fig. 2). The
diselenides [3,4] and the selenide [2] exhibited a dose-
dependent inhibiting effect on the formation of the ABTS•+
radical cation (P < 0.001 versus Ebselen) at 5.10-5 and
10-4 M). Selenide [1] and Ebselen showed a less pro-
nounced dose-dependent inhibitory effect (P < 0.001
versus control at 10-4 and 5.10-5 M). The order of effi-
cacy of the compounds tested in this model was as fol-
lows: [4] > [3] > [2] > Ebselen = [1].
EPR spin trapping investigation of the effect of Ebselen
and its analogues on the thiyl radical generation
The peroxidase-catalysed oxidation system allowed
investigation of the formation of the thiyl (GS•) radical
intermediate triggered by the addition of H2O2 in the
presence of a peroxidase (HRP). This system was
designed to assess the capability of Ebselen or its ana-
logues to protect glutathione from the oxidant attack by
the H2O2/HRP couple.
Figure 3 shows the EPR spectrum characteristic of the
thiyl radical produced by the enzymatic system
HRP/GSH/H2O2 in the presence of 100 mM DMPO.
This four-line EPR spectrum (with aN [coupling constant
of nitrogen] = 15.4 G and aH [coupling constant of
hydrogen] = 16.2 G), was totally abolished when 10–4 M
Ebselen was added to the reaction mixture (Fig. 3F). A
similar inhibition was obtained for compounds [3] and
[1], the latter compound being slightly less active (Fig.
3G,H). The selenide derivative [2] only induced 55%
inhibition while the diselenide [4] was inactive with the
same signal as the control possibly with a slight increase
(Fig. 3E). In the absence of HRP, no EPR spectrum was
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Fig. 1. Effect of Ebselen analogues [1–4] on in vitro lipid peroxidation (linoleic acid) induced by γ-radiation: comparison with Ebselen. Values are the
mean ± SD of nine assays. P < 0.001 versus Ebselen was considered as extremely significant and P < 0.05 versus Ebselen was significant.
observed (Fig. 3C), and only a very weak EPR signal
appeared in the absence of GSH (Fig. 3D). DMSO, used
as a vehicle for the studied compounds, was without
effect on the EPR spectrum (Fig. 3B). The efficacy of
the compounds tested in this model can be summarized
as follows: Ebselen = [3] > [1] > [2] > [4].
DISCUSSION
Using four experimental models, we demonstrated that
four Ebselen derivatives exhibited an antioxidant activ-
ity, but with variable efficiencies in relation to the exper-
imental model. Two models were designed to investigate
the GPx mimicking activity and antioxidant capability –
the kinetic method of H2O2 reduction and the EPR study
of thiyl radical formation. The kinetic method showed
that the rate of the catalytic reduction of H2O2 was
slightly accelerated by Ebselen (taken as control drug) or
the selenide derivatives [1,2]. Interestingly, we found
that selenide derivative [1] increased the rate of the cat-
alytic reduction of H2O2 more than Ebselen. From the
results obtained with this model, it can be stated that the
enhancement of the catalytic reduction was linked to the
presence of a selenium atom in the structure of the com-
pound, but that the presence of selenium atom could not
explain the variable effects of the tested compounds.
According to the kinetic studies of Mugesh et al.,8 the
diselenides with quite strong Se–N intramolecular inter-
actions did not show noticeable activity, whereas the dis-
elenides with an in-built co-ordinating basic amino
group but no Se–N interaction showed excellent activity.
These authors also reported that the diselenides, in
which the selenium atom was directly bonded to a
redox-active group such as ferrocenyl, showed a dra-
matic increase in peroxidase activity. The presence of
the tertiary amine function in the structure of the dise-
lenide compounds would also play a pivotal role,
because it activated the Se–Se bond and stabilized the
resulting selenic acid intermediate against further oxida-
tion.6,7 We found that the compounds [4] and [1], which
do not bear the tertiary amine function, behaved as good
catalysts for the reduction of hydrogen peroxide and that
compound [3] bearing a basic amino group with weak
Se–N interaction and compound [2] without Se–N inter-
action also showed a good GPx activity compared to
Ebselen. These results led us to use another model for
studying the oxidation phenomenon of Ebselen and its
analogues, based on a peroxidase-catalyzed oxidation
system and using the EPR spin trapping methodology as
previously described.17 The use of H2O2 in this system
allowed the formation of ferryl species from peroxidase.
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Fig. 2. ABTS•+ radical cation formation from the MetMb/H2O2/ABTS system in phosphate buffer at pH 7.4 and assessment of the antioxidant activity of
selenides [1,2] and diselenides [3,4] compared to Ebselen. ABTS•+ radical cation formation was followed by the absorbance change at 734 nm. The results
are expressed as mean ± SD with control value (no Ebselen or Ebselen analogue) taken as 100% (n = 4). *P < 0.01 versus Ebselen; **P < 0.001 versus
Ebselen.
This predictive model has been already extended to the
study of oxidative phenomena occuring with antipsy-
chotic drugs.18,19 With this EPR method, we tested dise-
lenide [3,4] and selenide [1,2] compounds and could
monitor the ability of these compounds to prevent the
formation of thiyl radical species (GS•) formed from the
HRP/GSH/H2O2 system in the presence of 5,5-dimethyl-
1-pyrroline-N-oxide (DMPO) as spin trap. Only dise-
lenide [3] and Ebselen prevented the generation of
oxidized glutathione (GSSG) through its thiyl radical
form. Both compounds completely abolished the forma-
tion of the GS• radical, as illustrated by the disappear-
ance of the signal area of the DMPO–SG adduct.
Compounds [1,2] were less sensitive to the oxidation
phenomenon. Compound [4] exerted no effect on thiyl
radical formation because the intensity of the EPR spec-
trum remained identical to the control spectrum.
It is often evoked that the unique mechanism by which
Ebselen exerts its antioxidant activity is linked to GPx-
mimicking activity,14 but other studies suggested that
Ebselen may have radical scavenging properties. For
instance, it was reported that Ebselen is a peroxynitrite
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Fig. 3. Thiyl (GS•) radical produced by the enzymatic system (HRP/GSH/H2O2) and effects of synthetic analogues of Ebselen. (A) Complete system
HRP/GSH/H2O2 + DMPO; (B–D) complete system without DMSO, HRP or GSH, respectively; E–I) same as (A) with compound [4], Ebselen, and
compounds [3], [1] and [2], respectively. The results represent the average of three separate assays. Conversion time 40 ms, receiver gain 2 × 104 and
number of scans 4.
scavenger20 and that this scavenging activity is linked to
the capability of Ebselen to react with the peroxynitrite
radical intermediates.21 Our results on the lipid peroxida-
tion model indicated that Ebselen had an antiradical effect
less efficient than its analogues ([3] and [4]) and exerted its
antioxidant capacity mainly by the GPx-mimicking activ-
ity because, by the kinetic assays and EPR, we found that
Ebselen catalyzed the reduction of peroxide and inhibited
the formation of oxidant species, decreasing so the attack
of the substrate (e.g. thiol; Figs 2 and 3F,G). We also
demonstrated that the Ebselen analogue [3] exhibited both
profiles and should be used as a candidate for pharmaco-
logical investigation. Indeed, in the model of lipid peroxi-
dation, the diselenide derivatives [3,4] showed the best
inhibitory effect versus the reference drug Ebselen. To
confirm the results obtained in the lipid peroxidation
model, we evaluated the radical scavenging activity of
Ebselen and that of its analogues, by monitoring the for-
mation of the ABTS•+ radical cation by spectrophoto-
metry,22 in the presence or absence of the drug. The
diselenides [3,4] inhibited, in a dose-dependent manner,
the formation of the radical cation while the other com-
pounds were less efficient, except compound [2] which
displayed an inhibitory effect more pronounced than that
of Ebselen and derivative [1]. These findings, taken
together, indicated that Ebselen may exert its antioxidant
activity not only by its GPx-mimicking activity, but also by
the additional weak scavenging properties.
CONCLUSIONS
We tested four small and low-weight analogues of
Ebselen and demonstrated that these compounds might
have biological relevance, and that it should be interest-
ing to use the diselenide derivative [3] as a pharmaco-
logical tool in cellular model studies. We also
demonstrated that the main mechanism by which
Ebselen exerted its antioxidant property is essentially as
a GPx mimic, even if its anti-radical efficiency is weak.
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